logo
episode-header-image
Jun 2023
7m 1s

CAR-T Treatment in Myeloma: State of the...

European Hematology Association
About this episode
tail spinning
Up next
Jul 16
How to Start a Clinical Trial?
What does it take to design and lead a clinical trial in hematology? In this episode of EHA Unplugged, Prof. Elias K. Mai shares his experience transitioning from clinical practice to becoming a principal investigator, and how the EHA Clinical Research Training in Hematology (CRT ... Show More
18m 46s
Jul 3
How Experts Treat Multiple Myeloma
In this episode, Prof. Pieter Sonneveld is joined by Prof. Meletios Dimopoulos and Prof. Evangelos Terpos to discuss the updated EHA–EMN (European Myeloma Network) guidelines for the diagnosis, treatment and follow-up of multiple myeloma. The conversation explores how recent ther ... Show More
35m 39s
Jun 22
Where Are We Now With Immunotherapy in Multiple Myeloma?
Explore the latest advancements in immunotherapies for multiple myeloma, including CAR T-cell therapy, bispecific antibodies, and antibody-drug conjugates. In this episode, Dr. Paula Rodriguez Otero discusses the strategic sequencing of BCMA and explains why CAR-T cells should of ... Show More
22m 33s
Recommended Episodes
Sep 2025
S2 Episode 3: When Is the Best Time to Use CAR T-Cell Therapy in Multiple Myeloma?
Joseph Mikhael, MD, and Krina K. Patel, MD, MSc, discuss considerations for CAR T-Cell therapy in multiple myeloma, including age, access, and bridging therapy. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002715. ... Show More
24m 38s
Aug 2022
Jason Westin, MD, MS, FACP - Rising to the Occasion: Improving Outcomes in Leukemia, Lymphoma, and Multiple Myeloma With CAR T-Cell Therapy in Community Practice
Go online to PeerView.com/NMF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Chimeric antigen receptor T-cell (CAR T) therapy, a validated novel therapeutic strategy in leukemic and lymphoid malignancies, continues to provid ... Show More
1h 30m
Jan 2023
Episode 044: Myeloma Series, Pt.5 - Myeloma Treatment
<p class="" style="white-space:pre-wrap;">In this continuation of our myeloma series, we build on our prior discussion about myeloma pharmacology, this time discussing how to select the optimal regimen for treatment of our patients.</p><p class="" style="white-space:pre-wrap;">Co ... Show More
34m 19s
Jun 2024
EHA2024 Chronic Lymphocytic Leukemia Preview: The Road Ahead With Targeted Therapies
Join the experts for an in-depth discussion on the latest developments in targeted therapies for relapsed/refractory chronic lymphocytic leukemia (R/R CLL), and a look ahead to the upcoming EHA2024 conference. Credit available for this activity expires: 6/6/2025 Earn Credit / Lea ... Show More
33m 47s
Feb 2023
Episode 045: Myeloma Series, Pt.6- Myeloma Treatment in Transplant Ineligible Patients
<p class="" style="white-space:pre-wrap;">In this episode, we start with a little bit of story time about the history of myeloma treatments and how we got to the present day. We then finish off the episode with how this information helped us treat transplant ineligible patients. ... Show More
29m 14s
Mar 2024
Innovations in CAR T-Cell Therapy for Multiple Myeloma
<p><span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Drs. John Sweetenham and Shaji Kumar discuss the emergence of CAR T-cell therapy for multiple myeloma, its benefits and challenges for patients, and its potential role earlier in the treatment of diseas ... Show More
20m 55s
Dec 2024
263. Cytokines Everywhere All at Once: Approach to CRS and ICANS
Send us Fan MailAs a result of the rapid adoption CAR-T therapy for certain lymphoid malignancies and multiple myeloma, of these treatments, CRS and ICANS will become more common in IM wards in the coming years. Take a listen to learn about how to treat this emerging condition. T ... Show More
17m 17s
Feb 2023
Episode 047: Myeloma Series, Pt.8- Myeloma Maintenance Therapy
tail spinning
30m 11s
May 2022
S1 Episode 2: Frontline Therapy for Multiple Myeloma
Joseph Mikhael, MD, and Peter Voorhees, MD, discuss frontline therapy for multiple myeloma and new options for both transplant-eligible and transplant-ineligible patients. Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/view ... Show More
23m 37s
Aug 2024
EHA 2024 Recap: Optimizing the Relapsed/Refractory CLL Treatment Pathway
<p>How can you optimize the treatment pathway for relapsed or refractory chronic lymphocytic leukemia (CLL)? Join the experts as they delve into the latest updates from EHA 2024.<br />   <br /> Credit available for this activity expires: 07/31/25<br /> Earn Credit / Learning Obje ... Show More
37m 22s